- Home
- SRBK vs ME Comparison
SRBK vs ME Comparison
Compare SRBK & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRBK
- ME
- Stock Information
- Founded
- SRBK 1887
- ME 2006
- Country
- SRBK United States
- ME United States
- Employees
- SRBK N/A
- ME N/A
- Industry
- SRBK
- ME Precision Instruments
- Sector
- SRBK
- ME Health Care
- Exchange
- SRBK Nasdaq
- ME Nasdaq
- Market Cap
- SRBK 105.9M
- ME 113.9M
- IPO Year
- SRBK N/A
- ME N/A
- Fundamental
- Price
- SRBK $12.06
- ME $3.20
- Analyst Decision
- SRBK
- ME Hold
- Analyst Count
- SRBK 0
- ME 1
- Target Price
- SRBK N/A
- ME $9.40
- AVG Volume (30 Days)
- SRBK 31.5K
- ME 299.9K
- Earning Date
- SRBK 01-01-0001
- ME 02-05-2025
- Dividend Yield
- SRBK N/A
- ME N/A
- EPS Growth
- SRBK N/A
- ME N/A
- EPS
- SRBK 0.11
- ME N/A
- Revenue
- SRBK $30,867,000.00
- ME $193,260,000.00
- Revenue This Year
- SRBK N/A
- ME $21.93
- Revenue Next Year
- SRBK N/A
- ME $17.31
- P/E Ratio
- SRBK $106.64
- ME N/A
- Revenue Growth
- SRBK 164.18
- ME N/A
- 52 Week Low
- SRBK $8.94
- ME $2.66
- 52 Week High
- SRBK $12.46
- ME $19.34
- Technical
- Relative Strength Index (RSI)
- SRBK 60.97
- ME 40.58
- Support Level
- SRBK $11.83
- ME $3.03
- Resistance Level
- SRBK $12.19
- ME $3.38
- Average True Range (ATR)
- SRBK 0.24
- ME 0.31
- MACD
- SRBK 0.01
- ME 0.02
- Stochastic Oscillator
- SRBK 67.74
- ME 15.79
About SRBK SR Bancorp Inc. Common stock
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.